Endpoints News 2025-12-11 Rhythm reports Imcivree’s key weight loss data from Phase 2 Prader-Willi trial
FierceBiotech 2025-12-11 Lilly's obesity triple threat smashes efficacy expectations in phase 3 but proves intolerable for some
FierceBiotech 2025-12-11 Rezolute's stock plunges 87% after hypoglycemia drug flunks pivotal phase 3 test
FierceBiotech 2025-12-11 FDA clears Lumosity brain training games as a prescription app for adult ADHD
Illumina 2025-12-11 Your lab’s new best friend for scalable proteomics: Illumina Protein Prep - Illumina
Endpoints News 2025-12-11 AC Immune says early biomarker data are promising in Parkinson's, but clinical benefit remains unclear
Illumina 2025-12-11 Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually - marketscreener.com
Endpoints News 2025-12-11 Corbus’ obesity pill posts muted weight loss data; Disco adds another €16M in seed funding
Thermo Fisher 2025-12-11 Citigroup Upgrades Thermo Fisher Scientific (TMO), Raises Price Target | TMO Stock News - GuruFocus
Illumina 2025-12-11 Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually | Newswise - Newswise
Illumina 2025-12-11 Illumina (NASDAQ: ILMN) invests in MyOme to launch AI-driven WGS trial in 2026 - Stock Titan
Illumina 2025-12-11 Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually - PR Newswire